0
Editor's Correspondence |

Goal Blood Pressure in Treating Hypertension—Reply

Norman M. Kaplan, MD
Arch Intern Med. 2002;162(1):106. doi:.
Text Size: A A A
Published online

Extract

In reply

Dr Ames raises an important issue about the relatively weak evidence available to support the recommendation for the lower goal BP of therapy in diabetic patients with hypertension that has been advocated by multiple expert committees and authorities over the past few years.13 However, there is both experimental and clinical evidence to support the goal of 130/80 mm Hg in addition to that provided in the HOT trial4 and the MDRD trial.5 Before considering that additional evidence, it should be noted that, in Dr Ames's own words, "The only impressive end point reduction in the diabetic cohort [of the HOT trial] with target diastolic BP of 80 mm Hg was cardiovascular mortality (P<.016)." Why would this significant reduction in mortality, even if it were not "the primary prespecified end point," not be accepted by even the most rigid and conservative observer as strong evidence for using the diastolic BP goal of 80 mm Hg?

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
The absence of intrarenal ACE protects against hypertension.
The Journal of clinical investigation ;
[Posterior reversible encephalopathy syndrome induced by acute postinfectious glomerulonephritis.]
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie ;
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure